FFF Enterprises: BioSupply Trends


	CMS Proposes to Expand Access to Seasonal Influenza Immunization The Centers for Medicare & Medicaid Services (CMS) today proposed new requirements for Medicare-certified providers that are designed to expand access to seasonal influenza vaccination. Read the full article » US On Track for Most Measles Cases in a Decade The United States seems to be on track to have more measles cases than any year in more than a decade, with virtually all cases linked to other countries, including Europe where there's a big outbreak. Read the full article »

AlphaNine SD Price Reduced

A limited supply of AlphaNine SD, a lyophilized preparation for IV treatment and control of bleeding in patients with Factor IX deficiency, is now steeply discounted. To take advantage if this short-term pricing, please contact FFF at (800) 843-7477.

Spotlight on Gammaplex
Immune Globulin Intravenous (Human)

For IVIG treatment of PIDD patients, consider Gammaplex 5% liquid, made without sucrose, glucose or maltose. With low IgA, competitive infusion time and no refrigeration required, Gammaplex is a proven option for replacement therapy. Call (800) 843-7477 for more details about Gammaplex.

Pricing Promotion on Kogenate FS

Bayer's antihemophilic factor (recombinant) for the treatment of hemophilia A is specially priced at $0.60/IU while supplies last. Contact FFF’s Wow! Customer Care at (800) 843-7477 to place your order.

Product	Outpatient Hospital	Physician's Office

Carimune NF	61.817	62.406
Flebogamma 5% DIF	70.764	71.438
Gammagard Liquid	76.052	76.776
Gammagard S/D	61.817	62.406
Gamunex	74.586*	74.586
Octagam	74.512	75.222
Privigen	69.567	70.230

*ASP + 6% (Medicare pass-through drug)
Rates per gram are effective April 1, 2011 through June 30, 2011

From HealthCanal
Scientists Unveil 'Switch' that Could Help Design New Vaccines and Treatments for Autoimmune Diseases
more »

From The L.A. Times
UM Researchers Receive $23.4 Million to Research AIDS Vaccine
more »

From PR Newswire
FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
more »

From Talecris
Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement with FTC Staff
more »

From Reuters
Hepatitis C Cases Rising Among Massachusetts Youth
more »